The largest database of trusted experimental protocols

Basis fibroblast growth factor bfgf

Manufactured by Thermo Fisher Scientific
Sourced in United States

Basis fibroblast growth factor (bFGF) is a protein that stimulates the proliferation and differentiation of various cell types, including fibroblasts, endothelial cells, and chondrocytes. It is involved in the regulation of cellular processes such as wound healing, angiogenesis, and tissue repair.

Automatically generated - may contain errors

2 protocols using basis fibroblast growth factor bfgf

1

Schwann Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were differentiated into Schwann cell-like cells using a differentiation cocktail containing 0.14% Forskolin (Sigma-Aldrich corp., MO, USA), 0.01% basis fibroblast growth factor (bFGF; PeproTech, NJ, USA), 0.005% platelet-derived growth factor (PDGF-AA; PeproTech) and 0.02% Neuregulin-1 ß1 (NRG1-b1; R&D systems Inc, MN, USA).16 (link) Differentiation was assessed by immunocytochemistry for the expression of S100 (S100; ThermoFisher Scientific, MA, USA), Glial fibrillary acidic protein (GFAP, mouse anti-GFAP; ThermoFisher Scientific) and neurotrophin receptor p75 (p75 NTR, rabbit anti-p75 NTR; ThermoFisher Scientific). Goat anti-rabbit fluorescein isothiocyanate (FITC) and goat anti-mouse cyanine 3 (CY3, both ThermoFisher Scientific) were used as secondary antibodies. Cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI).
+ Open protocol
+ Expand
2

Schwann Cell Differentiation of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were differentiated into Schwann cell-like cells according to protocol17 (link). This protocol has shown to morphologically change 81.5% of the MSCs exposed to the differentiation medium into a typical spindle-like shape17 (link). Cells were treated with ß-mercaptoethanol (Sigma-Aldrich, MO, USA) and all-trans-retinoic acid (1:1000 of stock dilution, 35 μg/mL diluted in dimethyl sulfoxide (DMSO); Sigma-Aldrich), prior to introducing a differentiation solution to the growth medium containing 0.14% Forskolin (10 mM dissolved in DMSO, Sigma-Aldrich), 0.01% basis fibroblast growth factor (bFGF; 100 mg/mL dissolved in 5 mM Tris Hydrochloride buffer, PeproTech, NJ, USA), 0.005% platelet-derived growth factor (PDGF-AA; 100 mg/mL dissolved in 10 mM acetic acid, PeproTech) and 0.02% Neuregulin-1 ß1 (NRG1-b1; 100 μg/mL reconstituted in phosphate buffered saline (PBS), R&D systems Inc, MN, USA). Successful differentiation was previously assessed by immunohistochemistry18 .
All MSC cultures were maintained at subconfluent levels in a 37 °C incubator with 5% CO2 and passaged with TrypLE (Invitrogen, UK). Growth medium was changed every 72 hours. In this experiment, passage five cells were used to seed allografts.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!